SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007838
Filing Date
2016-08-10
Accepted
2016-08-10 07:31:04
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20160630x10q.htm 10-Q 1792860
2 EX-31.1 edit-20160630ex311d0438d.htm EX-31.1 18640
3 EX-31.2 edit-20160630ex312ad8a7a.htm EX-31.2 18194
4 EX-32.1 edit-20160630ex3211d21ed.htm EX-32.1 13720
  Complete submission text file 0001558370-16-007838.txt   5801100

Data Files

Seq Description Document Type Size
5 EX-101.INS edit-20160630.xml EX-101.INS 1079064
6 EX-101.SCH edit-20160630.xsd EX-101.SCH 45552
7 EX-101.CAL edit-20160630_cal.xml EX-101.CAL 34036
8 EX-101.DEF edit-20160630_def.xml EX-101.DEF 173959
9 EX-101.LAB edit-20160630_lab.xml EX-101.LAB 427883
10 EX-101.PRE edit-20160630_pre.xml EX-101.PRE 283944
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 161819968
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences